Hasil Pencarian - Toth PP

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

    Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease oleh Toth PP

    Diterbitkan 2016-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era

    Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era oleh Toth PP

    Diterbitkan 2016-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease

    Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease oleh Toth PP

    Diterbitkan 2014-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Dyslipidemia in women: etiology and management

    Dyslipidemia in women: etiology and management oleh Phan BAP, Toth PP

    Diterbitkan 2014-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Ezetimibe therapy: mechanism of action and clinical update

    Ezetimibe therapy: mechanism of action and clinical update oleh Phan BAP, Dayspring TD, Toth PP

    Diterbitkan 2012-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients

    Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk St... oleh Toth PP, Philip S, Hull M, Granowitz C

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy

    Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy oleh Toth PP, Thakker KM, Jiang P, Padley RJ

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

    PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab oleh Blom DJ, Dent R, Castro RC, Toth PP

    Diterbitkan 2016-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

    Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers oleh Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R

    Diterbitkan 2012-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

    Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy oleh Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

    Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease oleh Power TP, Ke X, Zhao Z, Bonine NG, Cziraky MJ, Grabner M, Barron JJ, Quimbo R, Vangerow B, Toth PP

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: